Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

A targeted needs assessment to improve referral patterns for palliative radiation therapy.

Parker SM, Wei RL, Jones JA, Mattes MD.

Ann Palliat Med. 2019 Sep;8(4):516-522. doi: 10.21037/apm.2019.08.02.

2.

Multistate hybrid time-dependent density functional theory with surface hopping accurately captures ultrafast thymine photodeactivation.

Parker SM, Roy S, Furche F.

Phys Chem Chem Phys. 2019 Sep 21;21(35):18999-19010. doi: 10.1039/c9cp03127h. Epub 2019 Aug 29.

PMID:
31465041
3.

Expanding the Scope of RNA Metabolic Labeling with Vinyl Nucleosides and Inverse Electron-Demand Diels-Alder Chemistry.

Kubota M, Nainar S, Parker SM, England W, Furche F, Spitale RC.

ACS Chem Biol. 2019 Aug 16;14(8):1698-1707. doi: 10.1021/acschembio.9b00079. Epub 2019 Jul 25.

PMID:
31310712
4.

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Günther OP, Gardy JL, Stafford P, Fluge Ø, Mella O, Tang P, Miller RR, Parker SM, Johnston SA, Patrick DM.

Mol Neurobiol. 2019 Jun;56(6):4249-4257. doi: 10.1007/s12035-018-1354-8. Epub 2018 Oct 8.

5.

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors.

Parker SM, Siochi RA, Wen S, Mattes MD.

Pract Radiat Oncol. 2019 Jan;9(1):e90-e97. doi: 10.1016/j.prro.2018.09.003. Epub 2018 Sep 27.

PMID:
30267899
6.

Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy.

Amin NP, Zainib M, Parker SM, Agarwal M, Mattes MD.

Adv Radiat Oncol. 2018 May 24;3(3):399-404. doi: 10.1016/j.adro.2018.04.015. eCollection 2018 Jul-Sep.

7.

Preventing chronic disease in patients with low health literacy using eHealth and teamwork in primary healthcare: protocol for a cluster randomised controlled trial.

Parker SM, Stocks N, Nutbeam D, Thomas L, Denney-Wilson E, Zwar N, Karnon J, Lloyd J, Noakes M, Liaw ST, Lau A, Osborne R, Harris MF.

BMJ Open. 2018 Jun 4;8(6):e023239. doi: 10.1136/bmjopen-2018-023239.

8.

Quadratic Response Properties from TDDFT: Trials and Tribulations.

Parker SM, Rappoport D, Furche F.

J Chem Theory Comput. 2018 Feb 13;14(2):807-819. doi: 10.1021/acs.jctc.7b01008. Epub 2017 Dec 28.

PMID:
29232511
9.

An Australian general practice based strategy to improve chronic disease prevention, and its impact on patient reported outcomes: evaluation of the preventive evidence into practice cluster randomised controlled trial.

Harris MF, Parker SM, Litt J, van Driel M, Russell G, Mazza D, Jayasinghe UW, Smith J, Del Mar C, Lane R, Denney-Wilson E; Preventive Evidence into Practice Partnership Group.

BMC Health Serv Res. 2017 Sep 8;17(1):637. doi: 10.1186/s12913-017-2586-4.

10.

'Chronic cough, cause unknown': A qualitative study of patient perspectives of chronic refractory cough.

Hulme K, Dogan S, Parker SM, Deary V.

J Health Psychol. 2019 May;24(6):707-716. doi: 10.1177/1359105316684204. Epub 2017 Jan 5.

PMID:
28810370
11.

Mechanism of photocatalytic water oxidation on small TiO2 nanoparticles.

Muuronen M, Parker SM, Berardo E, Le A, Zwijnenburg MA, Furche F.

Chem Sci. 2017 Mar 1;8(3):2179-2183. doi: 10.1039/c6sc04378j. Epub 2016 Dec 7.

12.

Psychological profile of individuals presenting with chronic cough.

Hulme K, Deary V, Dogan S, Parker SM.

ERJ Open Res. 2017 Mar 20;3(1). pii: 00099-2016. doi: 10.1183/23120541.00099-2016. eCollection 2017 Jan.

13.

Unphysical divergences in response theory.

Parker SM, Roy S, Furche F.

J Chem Phys. 2016 Oct 7;145(13):134105.

PMID:
27782443
14.

Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial.

Chamberlain Mitchell SA, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, Fowler SJ, Ludlow S, Hull JH, Chung KF, Lee KK, Bellas H, Pandyan A, Birring SS.

Thorax. 2017 Feb;72(2):129-136. doi: 10.1136/thoraxjnl-2016-208843. Epub 2016 Sep 28.

PMID:
27682331
15.

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.

Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S, Armand P, Fanale M, Ratanatharathorn V, Kuruvilla J, Cohen JB, Collins G, Savage KJ, Trneny M, Kato K, Farsaci B, Parker SM, Rodig S, Roemer MG, Ligon AH, Engert A.

Lancet Oncol. 2016 Sep;17(9):1283-94. doi: 10.1016/S1470-2045(16)30167-X. Epub 2016 Jul 20.

16.

The impact of health literacy and life style risk factors on health-related quality of life of Australian patients.

Jayasinghe UW, Harris MF, Parker SM, Litt J, van Driel M, Mazza D, Del Mar C, Lloyd J, Smith J, Zwar N, Taylor R; Preventive Evidence into Practice (PEP) Partnership Group.

Health Qual Life Outcomes. 2016 May 4;14:68. doi: 10.1186/s12955-016-0471-1.

17.

Implementing guidelines to routinely prevent chronic vascular disease in primary care: the Preventive Evidence into Practice cluster randomised controlled trial.

Harris MF, Parker SM, Litt J, van Driel M, Russell G, Mazza D, Jayasinghe UW, Del Mar C, Lloyd J, Smith J, Zwar N, Taylor R, Powell Davies G; Preventive Evidence into Practice Partnership Group.

BMJ Open. 2015 Dec 11;5(12):e009397. doi: 10.1136/bmjopen-2015-009397.

18.

Orbital Optimization in the Active Space Decomposition Model.

Kim I, Parker SM, Shiozaki T.

J Chem Theory Comput. 2015 Aug 11;11(8):3636-42. doi: 10.1021/acs.jctc.5b00429.

PMID:
26574446
19.

Unsupervised invariance learning of transformation sequences in a model of object recognition yields selectivity for non-accidental properties.

Parker SM, Serre T.

Front Comput Neurosci. 2015 Oct 7;9:115. doi: 10.3389/fncom.2015.00115. eCollection 2015.

20.

Lyme Disease Diagnosed by Alternative Methods: A Phenotype Similar to That of Chronic Fatigue Syndrome.

Patrick DM, Miller RR, Gardy JL, Parker SM, Morshed MG, Steiner TS, Singer J, Shojania K, Tang P; Complex Chronic Disease Study Group.

Clin Infect Dis. 2015 Oct 1;61(7):1084-91. doi: 10.1093/cid/civ470. Epub 2015 Jun 16.

PMID:
26082507
21.

Communication: Active space decomposition with multiple sites: density matrix renormalization group algorithm.

Parker SM, Shiozaki T.

J Chem Phys. 2014 Dec 7;141(21):211102. doi: 10.1063/1.4902991.

PMID:
25481122
22.

Quasi-diabatic States from Active Space Decomposition.

Parker SM, Shiozaki T.

J Chem Theory Comput. 2014 Sep 9;10(9):3738-44. doi: 10.1021/ct5004753. Epub 2014 Jul 23.

PMID:
26588519
23.

A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response.

Morice AH, Jakes AD, Faruqi S, Birring SS, McGarvey L, Canning B, Smith JA, Parker SM, Chung KF, Lai K, Pavord ID, van den Berg J, Song WJ, Millqvist E, Farrell MJ, Mazzone SB, Dicpinigaitis P; Chronic Cough Registry.

Eur Respir J. 2014 Nov;44(5):1149-55. doi: 10.1183/09031936.00217813. Epub 2014 Sep 3.

24.

Molecular junctions: can pulling influence optical controllability?

Parker SM, Smeu M, Franco I, Ratner MA, Seideman T.

Nano Lett. 2014 Aug 13;14(8):4587-91. doi: 10.1021/nl501629c. Epub 2014 Jul 31.

PMID:
25072807
25.

A phase I study of oral ixabepilone in patients with advanced solid tumors.

Deeken JF, Marshall JL, Pishvaian MJ, Hwang J, Ahlers CM, Clemens PL, Parker SM, Iacono L, LoRusso PM.

Cancer Chemother Pharmacol. 2014 May;73(5):1071-8. doi: 10.1007/s00280-014-2443-7. Epub 2014 Mar 25.

PMID:
24663504
26.

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma.

Feng Y, Masson E, Dai D, Parker SM, Berman D, Roy A.

Br J Clin Pharmacol. 2014 Jul;78(1):106-17. doi: 10.1111/bcp.12323.

27.

Bendamustine and rituximab for indolent B-cell non-hodgkin lymphoma in patients with compensated hepatitis C cirrhosis: a case series.

Parker SM, Hyder MA, Fesler MJ.

Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):e15-7. doi: 10.1016/j.clml.2013.07.002. Epub 2013 Sep 20. Review. No abstract available.

PMID:
24060287
28.

Communication: Active-space decomposition for molecular dimers.

Parker SM, Seideman T, Ratner MA, Shiozaki T.

J Chem Phys. 2013 Jul 14;139(2):021108. doi: 10.1063/1.4813827.

PMID:
23862922
29.

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.

Weber J, Hamid O, Amin A, O'Day S, Masson E, Goldberg SM, Williams D, Parker SM, Chasalow SD, Alaparthy S, Wolchok JD.

Cancer Immun. 2013 May 1;13:7. Print 2013.

30.

The effect of prolonged light intensity exercise in the heat on executive function.

Parker SM, Erin JR, Pryor RR, Khorana P, Suyama J, Guyette FX, Reis SE, Hostler D.

Wilderness Environ Med. 2013 Sep;24(3):203-10. doi: 10.1016/j.wem.2013.01.010. Epub 2013 Jun 17.

PMID:
23787402
31.

Experimental pediatric arterial ischemic stroke model reveals sex-specific estrogen signaling.

Herson PS, Bombardier CG, Parker SM, Shimizu T, Klawitter J, Klawitter J, Quillinan N, Exo JL, Goldenberg NA, Traystman RJ.

Stroke. 2013 Mar;44(3):759-63. doi: 10.1161/STROKEAHA.112.675124. Epub 2013 Jan 24.

32.

"Hyper-warburgism," a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin's lymphoma.

Elhomsy GC, Eranki V, Albert SG, Fesler MJ, Parker SM, Michael AG, Griffing GT.

J Clin Endocrinol Metab. 2012 Dec;97(12):4311-6. doi: 10.1210/jc.2012-2327. Epub 2012 Oct 9.

PMID:
23055548
33.

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM.

N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2.

34.

Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-β1-dependent mechanism.

Gorowiec MR, Borthwick LA, Parker SM, Kirby JA, Saretzki GC, Fisher AJ.

Free Radic Biol Med. 2012 Mar 15;52(6):1024-32. doi: 10.1016/j.freeradbiomed.2011.12.020. Epub 2012 Jan 2.

PMID:
22240154
35.

Coherent control of molecular torsion.

Parker SM, Ratner MA, Seideman T.

J Chem Phys. 2011 Dec 14;135(22):224301. doi: 10.1063/1.3663710.

PMID:
22168688
36.

Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma.

Weber JS, Hamid O, Chasalow SD, Wu DY, Parker SM, Galbraith S, Gnjatic S, Berman D.

J Immunother. 2012 Jan;35(1):89-97. doi: 10.1097/CJI.0b013e31823aa41c.

PMID:
22130166
37.

Shared care in mental illness: A rapid review to inform implementation.

Kelly BJ, Perkins DA, Fuller JD, Parker SM.

Int J Ment Health Syst. 2011 Nov 21;5:31. doi: 10.1186/1752-4458-5-31.

38.

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

Berman D, Parker SM, Siegel J, Chasalow SD, Weber J, Galbraith S, Targan SR, Wang HL.

Cancer Immun. 2010 Nov 24;10:11.

39.

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.

Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS.

Int J Hematol. 2009 Dec;90(5):616-622. doi: 10.1007/s12185-009-0444-9. Epub 2009 Nov 25.

PMID:
19937165
40.

Optically responsive gold nanorod-polypeptide assemblies.

Huang HC, Koria P, Parker SM, Selby L, Megeed Z, Rege K.

Langmuir. 2008 Dec 16;24(24):14139-44.

41.

Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation.

Borthwick LA, Parker SM, Brougham KA, Johnson GE, Gorowiec MR, Ward C, Lordan JL, Corris PA, Kirby JA, Fisher AJ.

Thorax. 2009 Sep;64(9):770-7. doi: 10.1136/thx.2008.104133. Epub 2009 Feb 12.

PMID:
19213777
42.

Age-dependent effects of testosterone in experimental stroke.

Cheng J, Hu W, Toung TJ, Zhang Z, Parker SM, Roselli CE, Hurn PD.

J Cereb Blood Flow Metab. 2009 Mar;29(3):486-94. doi: 10.1038/jcbfm.2008.138. Epub 2008 Nov 12.

43.

Airway epithelial cell senescence in the lung allograft.

Parker SM, Goriwiec MR, Borthwick LA, Johnson G, Ward C, Lordan JL, Corris PA, Saretzki GC, Fisher AJ.

Am J Transplant. 2008 Jul;8(7):1544-9. doi: 10.1111/j.1600-6143.2008.02284.x.

44.

Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review.

Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH.

Palliat Med. 2007 Sep;21(6):507-17. Review.

PMID:
17846091
45.

Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.

Kassel KM, Schulte NA, Parker SM, Lanik AD, Toews ML.

J Pharmacol Exp Ther. 2007 Oct;323(1):109-18. Epub 2007 Jul 19. Erratum in: J Pharmacol Exp Ther. 2007 Nov;323(2):757.

PMID:
17640953
46.

Discrepant perceptions about end-of-life communication: a systematic review.

Hancock K, Clayton JM, Parker SM, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH.

J Pain Symptom Manage. 2007 Aug;34(2):190-200. Epub 2007 Jun 4. Review.

PMID:
17544247
47.

A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information.

Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MH.

J Pain Symptom Manage. 2007 Jul;34(1):81-93. Epub 2007 May 25. Review.

PMID:
17531434
48.

T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.

Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H.

J Cereb Blood Flow Metab. 2007 Nov;27(11):1798-805. Epub 2007 Mar 28.

49.
50.

Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD.

J Immunol. 2006 Jun 1;176(11):6523-31.

Supplemental Content

Loading ...
Support Center